(NaturalNews) Several members of the Emergency Committee expert panel that advised the World Health Organization (WHO) during the swine flu pandemic have come forward admitting connections to the drug industry. A recent report revealed that five of the fifteen members on the panel had received some type of financial support from pharmaceutical companies either during or prior to the pandemic.
The panel was composed of members from almost every continent, and many were scientists and researchers. An entire list of panel members can be viewed here:
http://www.who.int/ihr/emerg_comm_members_2009/en/index.htmlDuring the outbreak,
WHO had concealed the names of these members to allegedly protect them from public pressure, but WHO denies allegations that panel member connections to drug
companies were conflicts of interests.
Some
experts expressed concern that panel member connections to the
drug industry played a role in helping them to secure large orders for vaccines around the world, especially since these members had received funding from
drug companies specifically for
pandemic flu research.
Nancy Cox, a panel member from the U.S. Centers for Disease Control and Prevention, admitted to receiving financial support from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) for flu vaccine
research, for instance. And Professor Arnold Monto, another panel member, revealed that he consults with major drug companies like GlaxoSmithKline, Novartis, Roche, Baxter and Sanofi Pasteur.
But WHO denies any foul play, insisting that these connections "do not give rise to a conflict of interest such that the experts concerned should be partially or totally excluded from participation in the Emergency Committee".
Sources for this story include:http://www.google.com/hostednews/afp/article/ALeqM5ifwZFBD8rvvsxIpb_Q0q8AAKjOKQ
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Share this article on: 
Now Available from 
